A detailed history of Rice Partnership, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rice Partnership, LLC holds 20,252 shares of LLY stock, worth $15.9 Million. This represents 3.05% of its overall portfolio holdings.

Number of Shares
20,252
Previous 23,837 15.04%
Holding current value
$15.9 Million
Previous $21.1 Million 25.97%
% of portfolio
3.05%
Previous 4.35%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

SELL
$727.2 - $932.06 $2.61 Million - $3.34 Million
-3,585 Reduced 15.04%
20,252 $15.6 Million
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $307,311 - $382,087
398 Added 1.7%
23,837 $21.1 Million
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $75,386 - $94,540
104 Added 0.45%
23,439 $21.2 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $822,565 - $1.1 Million
-1,389 Reduced 5.62%
23,335 $18.2 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $609,220 - $718,190
-1,160 Reduced 4.48%
24,724 $14.4 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $1.88 Million - $2.59 Million
-4,324 Reduced 14.31%
25,884 $13.9 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $16,484 - $22,042
-47 Reduced 0.16%
30,208 $14.2 Million
Q1 2023

Apr 27, 2023

BUY
$310.63 - $364.82 $134,813 - $158,331
434 Added 1.46%
30,255 $10.4 Million
Q4 2022

Jan 26, 2023

BUY
$321.55 - $374.67 $78,458 - $91,419
244 Added 0.82%
29,821 $0
Q3 2022

Nov 02, 2022

BUY
$296.48 - $337.87 $1.41 Million - $1.6 Million
4,739 Added 19.08%
29,577 $9.56 Million
Q2 2022

Jul 22, 2022

BUY
$278.73 - $327.27 $130,724 - $153,489
469 Added 1.92%
24,838 $8.05 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $978,657 - $1.22 Million
4,170 Added 20.64%
24,369 $6.98 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $286,683 - $355,776
-1,275 Reduced 5.94%
20,199 $5.58 Million
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $1.81 Million - $2.23 Million
8,189 Added 61.64%
21,474 $4.96 Million
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $1.01 Million - $1.3 Million
5,567 Added 72.13%
13,285 $3.05 Million
Q1 2021

May 11, 2021

BUY
$164.32 - $212.72 $1.04 Million - $1.35 Million
6,355 Added 466.25%
7,718 $1.44 Million
Q4 2020

Feb 09, 2021

BUY
$130.46 - $172.63 $177,816 - $235,294
1,363 New
1,363 $230,000
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $184,675 - $213,611
-1,263 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $102,724 - $123,627
-753 Reduced 37.35%
1,263 $207,000
Q4 2019

Jan 30, 2020

BUY
$106.92 - $132.43 $215,550 - $266,978
2,016 New
2,016 $265,000
Q2 2019

Jul 25, 2019

SELL
$110.79 - $129.32 $247,283 - $288,642
-2,232 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$111.31 - $131.02 $11,019 - $12,970
-99 Reduced 4.25%
2,232 $290,000
Q3 2018

Nov 15, 2018

BUY
$85.86 - $107.31 $200,139 - $250,139
2,331 New
2,331 $250,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $746B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rice Partnership, LLC Portfolio

Follow Rice Partnership, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Partnership, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Partnership, LLC with notifications on news.